Walker JL - Search Results

1

Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.

Brooks SE, Carter RL, Plaxe SC, Basen-Engquist KM, Rodriguez M, Kauderer J, Walker JL, Myers TK, Drake JG, Havrilesky LJ, Van Le L, Landrum LM, Brown CL. Brooks SE, et al. Among authors: walker jl. Gynecol Oncol. 2015 Jul;138(1):101-8. doi: 10.1016/j.ygyno.2015.04.033. Epub 2015 Apr 30. Gynecol Oncol. 2015. PMID: 25937529 Free PMC article. Clinical Trial.

2

Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace.

Scribner DR Jr, Walker JL. Scribner DR Jr, et al. Among authors: walker jl. Gynecol Oncol. 1998 Dec;71(3):458-60. doi: 10.1006/gyno.1998.5174. Gynecol Oncol. 1998. PMID: 9887250

3

Cost analysis of laparoscopy versus laparotomy for early endometrial cancer.

Scribner DR Jr, Mannel RS, Walker JL, Johnson GA. Scribner DR Jr, et al. Among authors: walker jl. Gynecol Oncol. 1999 Dec;75(3):460-3. doi: 10.1006/gyno.1999.5606. Gynecol Oncol. 1999. PMID: 10600307

4

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Rose PG, Brunetto VL, VanLe L, Bell J, Walker JL, Lee RB. Rose PG, et al. Among authors: walker jl. Gynecol Oncol. 2000 Aug;78(2):212-6. doi: 10.1006/gyno.2000.5865. Gynecol Oncol. 2000. PMID: 10926805 Clinical Trial.

5

A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.

Rose PG, Rodriguez M, Walker J, Greer B, Fusco N, McGuire W. Rose PG, et al. Gynecol Oncol. 2002 Apr;85(1):136-9. doi: 10.1006/gyno.2002.6584. Gynecol Oncol. 2002. PMID: 11925133 Clinical Trial.

6

Impact of individual physicians on enrollment of patients into clinical trials.

Mannel RS, Walker JL, Gould N, Scribner DR Jr, Kamelle S, Tillmanns T, McMeekin DS, Gold MA. Mannel RS, et al. Among authors: walker jl. Am J Clin Oncol. 2003 Apr;26(2):171-3. doi: 10.1097/00000421-200304000-00014. Am J Clin Oncol. 2003. PMID: 12714890

7

Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies.

Gold MA, Walker JL, Berek JS, Hallum AV 3rd, Garcia DJ, Alberts DS. Gold MA, et al. Among authors: walker jl. Gynecol Oncol. 2003 Aug;90(2):325-30. doi: 10.1016/s0090-8258(03)00319-6. Gynecol Oncol. 2003. PMID: 12893194 Clinical Trial.

8

A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?

Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS. Rutledge TL, et al. Among authors: walker jl. Gynecol Oncol. 2004 Oct;95(1):70-6. doi: 10.1016/j.ygyno.2004.07.027. Gynecol Oncol. 2004. PMID: 15385112

9

Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer.

McMeekin DS, Tillmanns T, Chaudry T, Gold M, Johnson G, Walker J, Mannel R. McMeekin DS, et al. Gynecol Oncol. 2004 Oct;95(1):157-64. doi: 10.1016/j.ygyno.2004.07.008. Gynecol Oncol. 2004. PMID: 15385126

10

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Burger RA, Clarke-Pearson D. Walker JL, et al. Gynecol Oncol. 2006 Jan;100(1):27-32. doi: 10.1016/j.ygyno.2005.11.013. Gynecol Oncol. 2006. PMID: 16368440 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

559 results

Search Page

Filters